SCHEMBL7902117

SCHEMBL7902117

O=C(O)c1ccc2cc(-c3ccc(O)cc3C34CC5CC(CC(C5)C3)C4)ccc2c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARG P13631 12/20 0.69
RARB P10826 11/20 0.69
RARA P10276 10/20 0.69
MEN1 O00255 3/20 0.69
KMT2A Q03164 3/20 0.69
KDM4E B2RXH2 1/20 0.69
ALDH1A1 P00352 1/20 0.69
TP53 P04637 1/20 0.69
CYP3A4 P08684 1/20 0.69
MAPT P10636 1/20 0.69
HPGD P15428 1/20 0.69
ALOX15 P16050 1/20 0.69
ALOX12 P18054 1/20 0.69
MAPK1 P28482 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
HSD17B10 Q99714 1/20 0.69
THRB P10828 1/20 0.61
RECQL P46063 1/20 0.61
NR2E1 Q9Y466 1/20 0.61
NR1I2 O75469 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9300831 0.85 RARB (0.69) RARGRARBRARAMEN1KMT2A
O-Demethylated Adapalene SCHEMBL174205 0.81 RARG (1.00) RARGRARBRARAMEN1KMT2A
O-Demethylated Adapalene SCHEMBL29727107 0.81 RARG (1.00) RARGRARBRARAMEN1KMT2A
O-Demethylated Adapalene SCHEMBL29357288 0.81 RARG (1.00) RARGRARBRARAMEN1KMT2A
O-Demethylated Adapalene SCHEMBL29357074 0.81 RARG (1.00) RARGRARBRARAMEN1KMT2A
SCHEMBL2912783 0.81 RARG (0.71) RARGRARBRARAMEN1KMT2A
SCHEMBL9331667 0.79 RARB (0.56) RARGRARBRARAMEN1KMT2A
SCHEMBL8766318 0.79 RARG (0.77) RARGRARBRARAMEN1KMT2A
Adapalene SCHEMBL4915067 0.79 RARB (0.92) RARGRARBRARAMEN1KMT2A
SCHEMBL12257861 0.79 MEN1 (0.74) RARGRARBRARAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110114338-B Retinoid derivatives having antitumor activity 比奥吉公司 2022-10-21 CN disclosed
US-20120183600-A1 NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME AND OTHER CONDITIONS CHEN CHIEN-HUNG (US) 2012-07-19 US disclosed
US-6211239-B1 Method for treating or preventing breast cancer or leukemia using 6-[3-[1-adamantyl]-4-hydroxyphenyl]-2-naphthalene carboxylic acid (AHPN) CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) 2001-04-03 US disclosed
EP-0850067-A4 METHOD FOR TREATING CANCERS USING 6- 3- 1-ADAMANTYL]-4-HYDROXYPHENYL] CIRD GALDERMA (FR) 1999-12-15 EP disclosed
EP-0850067-A1 METHOD FOR TREATING CANCERS USING 6- 3- 1-ADAMANTYL]-4-HYDROXYPHENYL] CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) 1998-07-01 EP disclosed
WO-1997003682-A1 METHOD FOR TREATING CANCERS USING 6-[3-[1-ADAMANTYL]-4-HYDROXYPHENYL] CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES C.I.R.D. GALDERMA (FR) 1997-02-06 WO disclosed